These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22285152)

  • 21. Glutamine as a pathogenic factor in hepatic encephalopathy.
    Albrecht J; Dolińska M
    J Neurosci Res; 2001 Jul; 65(1):1-5. PubMed ID: 11433423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.
    Cordoba J; Gottstein J; Blei AT
    Hepatology; 1996 Oct; 24(4):919-23. PubMed ID: 8855198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular aspects of hepatic encephalopathy].
    Márquez-Aguirre AL; Canales-Aguirre AA; Gómez-Pinedo U; Gálvez-Gastélum FJ
    Neurologia; 2010 May; 25(4):239-47. PubMed ID: 20609302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ammonia, glutamine, and serum on calcineurin, p38MAPK-diP, GADD153/CHOP10, and CNTF in primary rat astrocyte cultures.
    Bodega G; Suárez I; Paniagua C; Vacas E; Fernández B
    Brain Res; 2007 Oct; 1175():126-33. PubMed ID: 17888887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of Kir4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: Implications for astrocytic dysfunction in hepatic encephalopathy.
    Obara-Michlewska M; Pannicke T; Karl A; Bringmann A; Reichenbach A; Szeliga M; Hilgier W; Wrzosek A; Szewczyk A; Albrecht J
    J Neurosci Res; 2011 Dec; 89(12):2018-27. PubMed ID: 21538466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamine in the mechanism of ammonia-induced astrocyte swelling.
    Jayakumar AR; Rao KV; Murthy ChR; Norenberg MD
    Neurochem Int; 2006; 48(6-7):623-8. PubMed ID: 16517020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aquaporin-4 in hepatic encephalopathy.
    Rama Rao KV; Norenberg MD
    Metab Brain Dis; 2007 Dec; 22(3-4):265-75. PubMed ID: 17879149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
    Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
    Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes.
    Rama Rao KV; Jayakumar AR; Norenberg MD
    Neurochem Int; 2005 Jul; 47(1-2):31-8. PubMed ID: 15908047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy.
    Butterworth RF
    Neurochem Int; 2010 Nov; 57(4):383-8. PubMed ID: 20350577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress.
    Lemberg A; Fernández MA
    Ann Hepatol; 2009; 8(2):95-102. PubMed ID: 19502650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between cytokines and ammonia in the mitochondrial permeability transition in cultured astrocytes.
    Alvarez VM; Rama Rao KV; Brahmbhatt M; Norenberg MD
    J Neurosci Res; 2011 Dec; 89(12):2028-40. PubMed ID: 21748779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm.
    Schliess F; Görg B; Häussinger D
    Biol Chem; 2006; 387(10-11):1363-70. PubMed ID: 17081108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema.
    Sepehrinezhad A; Zarifkar A; Namvar G; Shahbazi A; Williams R
    Metab Brain Dis; 2020 Apr; 35(4):559-578. PubMed ID: 32146658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation in hepatic encephalopathy: mechanistic aspects.
    Jayakumar AR; Rama Rao KV; Norenberg MD
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S21-8. PubMed ID: 26041953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent insights into the pathogenesis of hepatic encephalopathy and treatments.
    Sturgeon JP; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):83-100. PubMed ID: 24236755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of hepatic encephalopathy in acute liver failure.
    Vaquero J; Chung C; Cahill ME; Blei AT
    Semin Liver Dis; 2003 Aug; 23(3):259-69. PubMed ID: 14523679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton spectroscopy of brain glutamine in acute liver failure.
    McConnell JR; Antonson DL; Ong CS; Chu WK; Fox IJ; Heffron TG; Langnas AN; Shaw BW
    Hepatology; 1995 Jul; 22(1):69-74. PubMed ID: 7601435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling factors in the mechanism of ammonia neurotoxicity.
    Norenberg MD; Rama Rao KV; Jayakumar AR
    Metab Brain Dis; 2009 Mar; 24(1):103-17. PubMed ID: 19104923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.